Ausgabe 3/2016
Inhalt (27 Artikel)
Note of clarification regarding data about the association between the interleukin-1β −31T>C polymorphism and breast cancer risk
Yadong Wang, Yan Wang, Li Li
Note of clarification regarding data on the association between the interleukin-1β −511C>T polymorphism and breast cancer risk
Yadong Wang, Xinwei Chu, Haiyu Wang
Natural history of age-related lobular involution and impact on breast cancer risk
Derek C. Radisky, Daniel W. Visscher, Ryan D. Frank, Robert A. Vierkant, Stacey Winham, Melody Stallings-Mann, Tanya L. Hoskin, Aziza Nassar, Celine M. Vachon, Lori A. Denison, Lynn C. Hartmann, Marlene H. Frost, Amy C. Degnim
Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin
Marcia R. Campbell, Hui Zhang, Shabnam Ziaee, Ana Ruiz-Saenz, Nathaniel Gulizia, Julie Oeffinger, Dhara N. Amin, Deepika Ahuja, Mark M. Moasser, Catherine C. Park
High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation
Xiaoqin Huang, Dan He, Jia Ming, Yubin He, Champion Zhou, Hui Ren, Xin He, Chenguang Wang, Jingru Jin, Liang Ji, Belinda Willard, Bing Pan, Lemin Zheng
HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline
Yao-Shan Fan, Carmen E. Casas, Jinghong Peng, Melanie Watkins, Lynn Fan, Jennifer Chapman, Offiong Francis Ikpatt, Carmen Gomez, Wei Zhao, Isildinha M. Reis
Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer
Giuseppe Viale, Leen Slaets, Femke A. de Snoo, Jan Bogaerts, Leila Russo, Laura van’t Veer, Emiel J. T. Rutgers, Martine J. Piccart-Gebhart, Lisette Stork-Sloots, Patrizia Dell’Orto, Annuska M. Glas, Fatima Cardoso
The effect of resistance training on markers of immune function and inflammation in previously sedentary women recovering from breast cancer: a randomized controlled trial
Amanda D. Hagstrom, Paul W. M. Marshall, Chris Lonsdale, Shona Papalia, Birinder S. Cheema, Catherine Toben, Bernhard T. Baune, Maria A. Fiatarone Singh, Simon Green
Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor
Brandon S. Sheffield, Zuzana Kos, Karama Asleh-Aburaya, Xiu Qing Wang, Samuel Leung, Dongxia Gao, Jennifer Won, Christine Chow, Rakesh Rachamadugu, Inge Stijleman, Robert Wolber, C. Blake Gilks, Nickolas Myles, Tom Thomson, Malcolm M. Hayes, Philip S. Bernard, Torsten O. Nielsen, Stephen K. L. Chia
Effect of a randomized controlled exercise trial on bone outcomes: influence of adjuvant endocrine therapy
M. Tish Knobf, Sangchoon Jeon, Barbara Smith, Lyndsay Harris, Jane Kerstetter, A. Siobhan Thompson, Karl Insogna
Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS)
Alice C. Shapiro, Susan A. Adlis, Kim Robien, Mark N. Kirstein, Shuang Liang, Sara A. Richter, Rachel E. Lerner
Comparison of intra-operative specimen mammography to standard specimen mammography for excision of non-palpable breast lesions: a randomized trial
Cynthia L. Miller, Suzanne B. Coopey, Elizabeth Rafferty, Michele Gadd, Barbara L. Smith, Michelle C. Specht
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies
Amy Jo Chien, Alyson Cockerill, Craig Fancourt, Emmett Schmidt, Mark M. Moasser, Hope S. Rugo, Michelle E. Melisko, Andrew H. Ko, R. Katie Kelley, W. Michael Korn, Laura J. Esserman, Laura van‘t Veer, Christina Yau, Denise M. Wolf, Pamela N. Munster
Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium
Mia M. Gaudet, Myrto Barrdahl, Sara Lindström, Ruth C. Travis, Paul L. Auer, Julie E. Buring, Stephen J. Chanock, A. Heather Eliassen, Susan M. Gapstur, Graham G. Giles, Marc Gunter, Christopher Haiman, David J. Hunter, Amit D. Joshi, Rudolf Kaaks, Kay-Tee Khaw, I-Min Lee, Loic Le Marchand, Roger L. Milne, Petra H. M. Peeters, Malin Sund, Rulla Tamimi, Antonia Trichopoulou, Elisabete Weiderpass, Xiaohong R. Yang, Ross L. Prentice, Heather Spencer Feigelson, Federico Canzian, Peter Kraft
Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community
Michael J. Hassett, Wei Jiang, Laurel A. Habel, Larissa Nekhlyudov, Ninah Achacoso, Luana Acton, Stuart J. Schnitt, Deb Schrag, Rinaa S. Punglia
Impact of very low physical activity, BMI, and comorbidities on mortality among breast cancer survivors
Sandahl H. Nelson, Catherine R. Marinac, Ruth E. Patterson, Sarah J. Nechuta, Shirley W. Flatt, Bette J. Caan, Marilyn L. Kwan, Elizabeth M. Poole, Wendy Y. Chen, Xiao-ou Shu, John P. Pierce
Associations of sex steroid hormones with mortality in women with breast cancer
Catherine Duggan, Frank Stanczyk, Kristin Campbell, Marian L. Neuhouser, Richard N. Baumgartner, Kathy B. Baumgartner, Leslie Bernstein, Rachel Ballard, Anne McTiernan
Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers
Ines Vaz-Luis, Melissa E. Hughes, Angel Cronin, Hope S. Rugo, Stephen B. Edge, Beverly Moy, Richard L. Theriault, Michael J. Hassett, Eric P. Winer, Nancy U. Lin
Healthy dietary patterns and risk of breast cancer by molecular subtype
Kelly A. Hirko, Walter C. Willett, Susan E. Hankinson, Bernard A. Rosner, Andrew H. Beck, Rulla M. Tamimi, A. Heather Eliassen
Clinical predictors of long-term survival in HER2-positive metastatic breast cancer
Pooja Murthy, Kelley M. Kidwell, Anne F. Schott, Sofia D. Merajver, Jennifer J. Griggs, Jeffrey D. Smerage, Catherine H. Van Poznak, Max S. Wicha, Daniel F. Hayes, N. Lynn Henry
Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens
D. G. Evans, F. Lalloo, S. Howell, S. Verhoef, E. R. Woodward, A. Howell
Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm
Lynn Jongen, Robert Paridaens, Giuseppe Floris, Hans Wildiers, Patrick Neven
Erratum to: Recombinant viral protein VP1 suppresses HER-2 expression and migration/metastasis of breast cancer
Shao-Wen Hung, Ching-Feng Chiu, Tai-An Chen, Chiao-Li Chu, Chi-Chang Huang, Lie-Fen Shyur, Chi-Ming Liang, Shu-Mei Liang
Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
Ziyan Yuan Pessetto, Ying Yan, Tadayoshi Bessho, Amarnath Natarajan
Erratum to: CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis
Subir Biswas, Suman Sengupta, Sougata Roy Chowdhury, Samir Jana, Gunjan Mandal, Palash Kumar Mandal, Nipun Saha, Vivek Malhotra, Arnab Gupta, Dmitry V. Kuprash, Arindam Bhattacharyya
Erratum to: Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice
Eun-Young Gil, Uk-Hyun Jo, Hye Jin Lee, Jinho Kang, Jae Hong Seo, Eun Sook Lee, Yeul Hong Kim, InSun Kim, Vy Phan-Lai, Mary L. Disis, Kyong Hwa Park
Erratum to: A nomogram based on mammary ductoscopic indicators for evaluating the risk of breast cancer in intraductal neoplasms with nipple discharge
Zhen-Qiang Lian, Qi Wang, An-Qin Zhang, Jiang-Yu Zhang, Xiao-Rong Han, Hai-Yun Yu, Si-Mei Xie